Lidds AB
Develops a drug delivery technology for local, controlled, and sustained release.
LIDDS | ST
Overview
Corporate Details
- ISIN(s):
- SE0001958612
- LEI:
- 549300YYW8B918K7UN72
- Country:
- Sweden
- Address:
- Box 12040, 112 40 Stockholm
- Website:
- https://liddspharma.com/en/
- Sector:
- Manufacturing
Description
Lidds AB is a pharmaceutical company specializing in drug delivery based on its proprietary NanoZolid® technology platform. This technology enables the local, controlled, and sustained release of drugs. A NanoZolid-formulated drug is administered as an injectable suspension that forms a solid, absorbable depot at the target site, releasing the active substance over a defined period. This approach is designed to increase local therapeutic effects while minimizing systemic side effects. The company is developing its own pipeline of products, with a primary focus on oncology. Key candidates in development include Liproca Depot for prostate cancer, Nanodotax (a formulation of the chemotherapy drug docetaxel), and Nanoimod (a TLR9 agonist). The versatile platform can be used to reformulate a wide range of drugs across various therapeutic areas.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Lidds AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Lidds AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Lidds AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-02-14 | Anders Månsson | Other | Buy | 100,000 | 140,000.00 SEK |
| 2023-02-10 | Matthew Lindon | Other | Buy | 71,428 | 99,999.20 SEK |
| 2023-02-09 | Daniel Lifveredson | Other | Other | 150,000 | 210,000.00 SEK |
| 2022-12-16 | Daniel Lifveredson | Other | Sell | 435,254 | 826,982.60 SEK |
| 2022-12-16 | Daniel Lifveredson | Other | Buy | 435,254 | 826,982.60 SEK |
| 2022-06-02 | Galba Holding AB | Other | Buy | 750,000 | 4,500,000.00 SEK |
| 2022-03-08 | Jan Törnell | Other | Buy | 5,000 | 32,500.00 SEK |
| 2021-06-30 | Nina Herne | Other | Other | 100,000 | 116,000.00 SEK |
| 2021-06-03 | Daniel Lifveredson | Other | Buy | 435,254 | 4,483,116.20 SEK |
| 2021-05-31 | Maria Forss | Other | Buy | 2,300 | 29,992.00 SEK |
Peer Companies
